Posted by ABMN Staff on May 6th, 2024
United Therapeutics (NASDAQ:UTHR – Free Report) had its target price lifted by Oppenheimer from $375.00 to $400.00 in a report released on Thursday morning, Benzinga reports. Oppenheimer currently has an outperform rating on...
More of this article »